TransMedics Group (TMDX) Misses Q4 EPS by 4c

TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.52 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ennis (EBF) Reports In-Line Q1 EPS
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth